pharma · PCOS · Stomach Neoplasms
Renji Hospital
RenJi Hospital
RenJi Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include PCOS, Stomach Neoplasms. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this
Shanghai, CN HQ
608 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Shanghai, CN
- Employees
- 608
- Programs
- 2
- Drugs
- 3
- Patents
- 0
Fruquintinib
Phase 2 · small molecule · Stomach Neoplasms
Fruquintinib for Stomach Neoplasms is a Phase 2 program (small_molecule) at RenJi Hospital with 1 ClinicalTrials.gov record(s).
Internal code HMPL-013-SH-GC-101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- RenJi Hospital
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Stomach Neoplasms
- Status
- active
- Trials
- 1